Home
Connective Tissue DiseaseMedia
Connective Tissue Disease
-
Multiplexing: Streamline Autoimmune Testing with MosaiQ AiPlex® CTDplus
In the world of autoimmune diagnostics, time and accuracy are everything. Traditional serological testing often involves multiple assays, manual steps, and long turnaround times. AliveDx is changing that with the MosaiQ® AiPlex CTDplus, a fully automated multiplex microarray immunoassay designed
-
How Machine Learning Is Transforming CTD Diagnosis
In-vitro diagnostics (IVD) is entering a new era, one where artificial intelligence (AI) and multiplexed immunoassays converge to deliver fast, smart and accurate results. At AliveDx, we’re proud to be at the forefront of this transformation with our MosaiQ® and
-
Unlocking Comprehensive Insights in Autoimmune Diagnostics: The Role of Anti-DFS70 Autoantibodies
Autoimmune connective tissue diseases1 (CTD) such as lupus, Sjögren’s syndrome, and systemic sclerosis present a diagnostic challenge due to overlapping symptoms and complex antibody profiles. At AliveDx, we’re committed to the challenge of simplifying that complexity through innovative in-vitro diagnostic
-
Machine learning classification based on a 15-autoantibody profile by a fully automated multiplex microarray immunoassay for autoimmune CTD diagnosis
Extended serological profiling may improve autoimmuneconnective tissue diseases (CTD) diagnosis.
-
Performance characteristics of Automated Immunoassay Microarray prototype detecting Centromere Protein B (CENP-B). AACC2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting Anti-Centromere Protein B (CENP-B) antibodies. Presented at AACC 2023.
-
Performance characteristics of Automated Immunoassay Microarray detecting Anti-Centromere Protein B antibodies. Immunochemistry & Immunopathology 2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting Anti-Centromere Protein B (CENP-B) antibodies.
-
Performance characteristics of Automated Immunoassay Microarray prototype analyzing simultaneously 11 IgG markers associated with Connective Tissue Diseases. ACR2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting 11 IgG antibodies associated with Connective Tissue Diseases. Presented at ACR 2023.
-
Analytical Performance of a Novel Automated Immunoassay Microarray analyzing simultaneously 15 markers associated with Connective Tissue Diseases. IFCC2024.
This study assesses the analytical performance of a novel automated immunoassay microarray for detecting 15 IgG antibodies associated with Connective Tissue Diseases. Presented at IFCC2024.
-
Analytical Evaluation of Automated Immunoassay Microarray analyzing simultaneously 11 markers associated with Connective Tissue Diseases in a Spanish Reference Laboratory. ADLM2024.
This study assesses the analytical performance of a novel automated immunoassay microarray for detecting 11 antibodies associated with Connective Tissue Diseases, in a Spanish Reference Laboratory. Presented at ADLM2024.
